Silver crumb arthritis is an inflammatory joint disease associated with silver crumb, which has a greater impact on the lives of patients.
In terms of clinical symptoms, the joints perform a variety. The most common are excruciating and exterior joints, such as fingers and toes. Patients often feel these small joints in pain, swelling, increased mobility pain and, at the beginning of the morning, a sense of rigidity, which may last for several hours. When the condition is severe, the scope of the joints is gradually restricted, which affects the fine movements of the hands, such as buttons, pens, etc., and can lead to mobility difficulties. Some patients are also burdened with large joints, such as knees, ankles, etc., and suffer from red and swollen inflammation and pain when walking or weighting. In addition to joint symptoms, skin damage is one of the important characteristics of silver crumb arthritis. Most patients have typical silver crumb rashes, expressed in red spots with clear borders, which cover multiple layers of silver and white crumbs, which can be found in various parts of the body, such as the scalp, the limbs stretching, the back, etc., and may be associated with joint symptoms. Some of the patients may also suffer from changes in their nails, such as increased nails, dimples, colour variations and even stripping.
Drug treatment is the main means of treatment. Inflammatory drugs can be used to mitigate mild to moderate pain and inflammation and to improve joint functions, such as Broven, but long-term use may have adverse effects such as gastrointestinal tracts. For patients with more severe conditions, traditional synthetics to improve their condition against rheumatism are an important option, and amamamite is one of the most common drugs that can inhibit the progress of arthritis, but during use indicators such as blood protocol, liver and kidney function need to be closely monitored because of the possible side effects of bone marrow inhibition, liver damage, etc. In recent years, the application of biological agents has brought new breakthroughs in the treatment of silver crumb arthritis. Biological agents, such as tumour causers, can be specifically targeted at inflammatory factors, effectively control conditions, improve joints and skin symptoms, and improve the quality of life of patients, but at relatively high prices, and take care of risks such as infection during use.
In addition to drug treatment, physiotherapy is indispensable. Appropriate joint exercise maintains and improves the activity of joints, such as stretching exercises. Where medical conditions permit, the patient may exercise aerobics in a moderate manner, such as walking, swimming, etc., to increase muscle strength and reduce the joint burden. For patients with severe joint malformations and functional impairments, surgical treatment, such as joint replacements, may be considered when the drug and physiotherapy is ineffective, but there are certain risks and post-operative rehabilitation problems.
In sum, silver crumb arthritis requires early diagnosis, early treatment and a combination of treatments to alleviate the suffering of patients and control the development of the disease.
